Raphael Bueno, MD, Appointed Inaguraul Fredric G. Levin Distinguished Chair in Thoracic Surgery and Lung Cancer Research at Brigham and Women’s Hospital

Raphael Bueno, MD, has been appointed the Inaugural Fredric G. Levin Distinguished Chair in Thoracic Surgery and Lung Cancer Research at Brigham and Women’s Hospital.

Raphael Bueno MD Headshot
Raphael Bueno, MD

Raphael Bueno, MD
Fredric G. Levin Distinguished Chair in Thoracic Surgery and Lung Cancer Research, Brigham and Women’s Hospital
Chief of Thoracic Surgery, Brigham and Women’s Hospital
Co-Director, Lung Center, Brigham and Women’s Hospital
Professor of Surgery, Harvard Medical School

Raphael Bueno, MD, is chief of thoracic surgery at Brigham and Women’s Hospital (BWH) and professor of surgery at Harvard Medical School. He completed his bachelor’s degree at Harvard College and medical training at Harvard Medical School/Massachusetts Institute of Technology. He subsequently trained in general surgery at BWH and thoracic surgery at Massachusetts General Hospital, and joined the BWH thoracic faculty in 1996. Over the past 21 years, Bueno has developed robust clinical and research portfolios at BWH.

His clinical focus is management of thoracic malignancies, including mesothelioma, lung cancer, and esophageal cancer. His main research interests center on the molecular events that lead to malignancy in mesothelioma and lung cancer. Specifically, Bueno focuses on developing biomarkers for diagnosis, prognosis, and predicting therapy in malignant pleural mesothelioma and lung cancer. His research also includes tumor sequencing and identification of targetable pathways. He runs a molecular biology lab at the George W. Thorn Medical Research Building and has been funded for almost two decades by the National Cancer Institute, Department of Defense, foundations and industry grants. He also invented, patented, and licensed several algorithms and medical devices for patient care. Bueno has also invented and continues to develop several novel surgical procedures.

Bueno is a member of numerous prestigious national and international professional societies. He has been an invited lecturer at teaching hospitals and universities around the country and internationally. At BWH, he has built the largest division of thoracic surgery in the US, with 21 faculty members and five affiliated network sites in New England, and co-founded the BWH Lung Center. Bueno continues to push the boundaries of what is possible in patient care.

Adam S. Kibel, MD, Appointed Elliott Carr Cutler Professor of Surgery in Urology at Harvard Medical School

Adam S. Kibel, MD, has been appointed the Elliott Carr Cutler Professor of Surgery in Urology at Harvard Medical School.

Adam S. Kibel, MD Headshot
Adam S. Kibel, MD


Adam S. Kibel, MD

Chief of Urology, Brigham and Women’s Hospital and Dana-Farber/Brigham and Women’s Cancer Center
Elliott Carr Cutler Professor of Surgery in Urology, Harvard Medical School

Adam S. Kibel, MD, is chief of Urology at Brigham and Women’s Hospital and Dana-Farber/Brigham and Women’s Cancer Center. He is the Elliot Carr Cutler Professor of Surgery in Urology at Harvard Medical School and serves as chairman of the Harvard Program in Urology (Longwood). Dr. Kibel received his undergraduate and medical degrees from Cornell University, completed a residency at the Harvard Urology Program and a fellowship at the Brady Urologic Institute at Johns Hopkins.

With a practice focused on minimally invasive treatments for urologic cancers, Dr. Kibel has been listed as one of America’s Top Doctors by Castle Connolly and named a top urologist by Boston Magazine. The author of over 250 peer-reviewed publications, Dr. Kibel’s research focuses on the identification of molecular markers of urologic tumors, adjuvant and neoadjuvant approaches to treatment of aggressive disease, and improved imaging of patients with urologic malignancies. His research has been supported by the National Cancer Institute, Department of Defense, American Cancer Society, American College of Surgeons and the American Foundation for Urologic Disease.

Simon G. Talbot, MD, Awarded $1M Department of Defense Grant for Multidisciplinary Study

Simon G. Talbot, MD, has been awarded a $1M Department of Defense (DoD) Congressionally Directed Medical Research Programs (CDMRP) Reconstructive Transplant Research Program (RTRP) grant to study the psychosocial predictors of outcomes in Vascularized Composite Allotransplant (VCA) patients.

Dr. Talbot will serve as the primary investigator on the multidisciplinary study “Psychosocial Predictors in VCA”, in partnership with co-investigators from the Department of Psychiatry – Sejal Shah, MD and Robert Edwards, PhD; the Orthopaedic and Arthritis Center for Outcomes Research (OrACORe) – Jeffrey N. Katz, MD, MSc and Elena Losina, PhD; Division of Plastic and Reconstructive Surgery – Matthew J. Carty, MD; and Department of Orthopaedic Surgery – George S. Dyer, MD.

Simon G. Talbot, MD

Simon G. Talbot, MD
Associate Surgeon, Division of Plastic and Reconstructive Surgery, Brigham and Women’s Hospital
Director, Upper Extremity Transplant Program, Brigham and Women’s Hospital
Associate Professor of Surgery, Harvard Medical School

Simon G. Talbot, MD, specializes in general plastic surgery, hand surgery and microsurgery. In addition, he is an attending physician in the Brigham and Women’s Hospital Burn Center and the surgical lead in the Hand Transplant Program.

His research involves neurologic regeneration and rehabilitation in the upper extremity. Collaborating with the Harvard School of Engineering and Applied Science, he is helping make important contributions to the fields of hand surgery, reconstruction, transplantation and rehabilitation.